European researchers brought a new drug administration method to the clinic. It is expected to allow patients to administer their own medication at home.
Rheumatoid arthritis is an age-related disorder responsible for significant pain and discomfort; in advanced stages it prevents patients from working. Current treatment relies on tumour necrosis factor alpha (TNF-α) blockers, a great cost to the healthcare system.
Further details: Novel therapy for rheumatoid arthritis